Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bilcare Global Clinical Supplies, a single-source provider of clinical trial supplies and services, has enhanced its global Phase III capabilities.
Subscribe to our email newsletter
Bilcare Global Clinical Supplies’s (GCS) latest Phase III investments include the upgrade of its Kalish large-scale bottling line at its US facility and an investment in new Pentapack blistering technology for expanded packaging capabilities in America and Europe.
Bilcare’s investment in the Pentapack CT1200L system allows the company to package high-volume runs for large-scale clinical trials and stability tests. This technology gives Bilcare GCS flexibility in trial design and execution to meet individual client needs.
The Pentapack system enables Bilcare GCS to design blister packaging configurations online using Trialpack Designer II packaging design software, and immediately implement them for production.
Vince Santa Maria, president of Bilcare GCS, Americas, said: “The Pentapack and the expanded Kalish lines are key components to taking Bilcare’s Phase III clinical trial services to the next level by leveraging state-of-the-art packaging technologies to deliver superior quality products in a highly flexible and efficient manner.”